|
|
Clinical studies on Cefamezin, a new Cephalosporin C derivative,
were performed with the following results.
1. Cefamezin was intramuscularly administered in a daily dose of 40〜100 mg/kg to 50 children with various
infections for 3 to 25 days. The therapeutic results were excellent in 37 patients, good
... |
